ロード中...
Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma
The oncogenic Kaposi's sarcoma–associated herpesvirus (KSHV) is a principal causative agent of primary effusion lymphoma (PEL), which is mostly seen in immunosuppressed patients. PEL is a rapidly progressing malignancy with a median survival time of approximately 6 months even under the convent...
保存先:
出版年: | Oncotarget |
---|---|
主要な著者: | , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Impact Journals LLC
2017
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5392335/ https://ncbi.nlm.nih.gov/pubmed/28407694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15444 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|